|
|
||||||||
1From the Departments of Human Genetics and 4Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; the 2Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands; 3Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands; the 5Department of Clinical Genetics, Central Manchester and Manchester Childrens University Hospitals NHS Trust, Manchester, United Kingdom; and the 6Department of Ophthalmology, University Medical Centre Utrecht, Utrecht, The Netherlands.
PURPOSE. Linkage intervals for erosive vitreoretinopathy (ERVR) and Wagner disease previously were found to overlap at 5q14.3. In a Japanese family with Wagner disease, a CSPG2/Versican splice site mutation (c.4004-2A
G) was recently reported that resulted in a 39-nucleotide exon 8 in-frame deletion. We investigated whether CSPG2/Versican was mutated in six Dutch families and one Chinese family with Wagner disease and in a family with ERVR.
METHODS. In all families, extensive ophthalmic examinations, haplotype analysis of the 5q14.3 region, and sequence analysis of CSPG2/Versican were performed. The effects of splice site mutations were assessed by reverse transcriptionpolymerase chain reaction (RT-PCR) and real-time quantitative RT-PCR (QPCR).
RESULTS. Three novel intron 7 sequence variants (c.4004-5T
C, c.4004-5T
A, c.4004-1G
A) were identified in seven families. The c.4004-5T
C variant was identified in four families with Wagner disease and a family with ERVR. The families were shown to carry the same 5q14.3 haplotype, strongly suggesting that this is a common Dutch founder variant. All three changes segregated with the disease in the respective families and were absent in 250 healthy individuals. In patients with the c.4004-5T
A and c.4004-1G
A variants, RT-PCR analysis of CSPG2/Versican showed activation of a cryptic splice site resulting in a 39-nt exon 8 in-frame deletion in splice variant V0. QPCR revealed a highly significant (P < 0.0001) and consistent increase of the V2 (>38-fold) and V3 (>12-fold) splice variants in all patients with intron 7 nucleotide changes and in a Chinese Wagner disease family, in which the genetic defect remains to be found.
CONCLUSIONS. Wagner disease and ERVR are allelic disorders. Seven of the eight families exhibit a variant in intron 7 of CSPG2/Versican. The conspicuous clustering of sequence variants in the splice acceptor site of intron 7 and the consistent upregulation of the V2 and V3 isoforms strongly suggest that Wagner disease and ERVR may belong to a largely overlooked group of diseases that are caused by mRNA isoform balance shifts, representing a novel disease mechanism.
This article has been cited by other articles:
![]() |
A. Ohno-Jinno, Z. Isogai, M. Yoneda, K. Kasai, O. Miyaishi, Y. Inoue, T. Kataoka, J.-S. Zhao, H. Li, M. Takeyama, et al. Versican and Fibrillin-1 Form a Major Hyaluronan-Binding Complex in the Ciliary Body Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2870 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P Meredith, A. J Richards, D. W Flanagan, J. D Scott, A. V Poulson, and M. P Snead Clinical characterisation and molecular analysis of Wagner syndrome Br. J. Ophthalmol., May 1, 2007; 91(5): 655 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Keller, M. J. Kelley, and T. S. Acott Extracellular Matrix Gene Alternative Splicing by Trabecular Meshwork Cells in Response to Mechanical Stretching Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1164 - 1172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |